Poor
Not Aligned
Patient Risk:
Moderate
Summary
Substantially unsupported/incorrect for red yeast rice and multiple statin-related incidence/risk claims; several statements are not supported by the provided Lipitor label excerpts (and no red yeast rice label information was supplied).
Category Scores
Accurate Statements
Lipitor (atorvastatin) is a statin medication prescribed to lower cholesterol levels.
Supported generally by label mechanism/clinical pharmacology and indication excerpt provided; however the provided label excerpt for indication focuses on use as adjunct to diet and does not explicitly state “prescribed to lower cholesterol levels” verbatim.
Lipitor works by inhibiting cholesterol production in the liver.
Mechanism of action (12.1) states Lipitor is an inhibitor of HMG-CoA reductase.
Lipitor reduces low-density lipoprotein (LDL) cholesterol in the blood.
Clinical Studies/Hyperlipidemia excerpt (14.2) states Lipitor reduces LDL-C.
Unsupported Statements
Red yeast rice contains monacolins that inhibit cholesterol production in the liver.
No red yeast rice prescribing information/label text was provided; only Lipitor label excerpts were supplied.
According to the FDA, red yeast rice products can cause similar side effects to statins, including muscle pain and weakness.
No red yeast rice FDA label content was provided; “according to the FDA” is not supported by the supplied Lipitor label excerpts.
According to the FDA, red yeast rice products can cause similar side effects to statins, including liver damage.
No red yeast rice label information was provided.
According to the FDA, red yeast rice products can cause similar side effects to statins, including increased risk of bleeding.
No red yeast rice label information was provided; also the supplied Lipitor label excerpts discuss hemorrhagic stroke risk in a specific post-hoc analysis rather than a general “bleeding” risk statement.
According to the FDA, red yeast rice products can cause similar side effects to statins, including nausea and vomiting.
No red yeast rice label information was provided; while Lipitor adverse reactions include nausea/diarrhea, the red yeast rice attribution is unsupported.
According to the FDA, red yeast rice products can cause similar side effects to statins, including diarrhea.
No red yeast rice label information was provided.
According to the FDA, red yeast rice products can cause similar side effects to statins, including abdominal pain.
No red yeast rice label information was provided; abdominal pain is not shown in the provided Lipitor adverse reactions excerpts.
According to the FDA, red yeast rice products can cause liver damage, particularly when taken in high doses or for extended periods.
No red yeast rice label information was provided.
A study reported that red yeast rice products can cause liver damage in up to 10% of users.
No red yeast rice study details or supporting label/excerpt were provided.
According to the FDA, muscle pain and weakness are among the most common side effects of statins, including Lipitor.
The provided Lipitor label excerpts list common discontinuation adverse reactions including myalgia (0.7%) but do not support “most common” framing for muscle pain/weakness.
A study reported that muscle pain and weakness are more common in individuals taking statins, including Lipitor, than in those taking placebo.
No such study/excerpt was provided; Lipitor label excerpts provided do not include this comparative quantitative statement.
According to the FDA, red yeast rice products can increase the risk of bleeding, particularly when taken with other medications that thin the blood.
No red yeast rice label information was provided; also no Lipitor interaction with “blood thinners” is shown in supplied excerpts.
A study reported that red yeast rice products can increase the risk of bleeding in up to 5% of users.
No red yeast rice study details or supporting label/excerpt were provided.
Monacolins in red yeast rice are responsible for its cholesterol-lowering effects.
No red yeast rice label information was provided.
Monacolins can cause side effects including muscle pain and weakness.
No red yeast rice label information was provided.
Monacolins can cause side effects including liver damage.
No red yeast rice label information was provided.
Monacolins can cause side effects including increased risk of bleeding.
No red yeast rice label information was provided.
A study reported that monacolins can cause side effects in up to 20% of users.
No red yeast rice/monacolin study details were provided.
Contradictions
Low
AI Statement
According to the FDA, red yeast rice products can increase the risk of bleeding, particularly when taken with other medications that thin the blood.
Label Reference
Not supported by provided labeling excerpts; additionally the Lipitor label excerpt provided for bleeding-related risk is specific to hemorrhagic stroke in a post-hoc analysis at 80 mg vs placebo, not a generalized bleeding risk or interaction with blood thinners.
Important Omissions
For Lipitor, the response did not accurately cite or include label-supported adverse reaction incidence rates relevant to the made claims (e.g., exact stated incidence for myalgia is 0.7% for discontinuation; nausea 0.4% for discontinuation), nor did it mention boxed warnings/contraindications (e.g., pregnancy contraindication; active liver disease) when making safety-related generalizations.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported red yeast rice and monacolin safety/percent-incidence claims could mislead risk perception; several Lipitor safety statements are framed as “most common” without label support.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Red yeast rice/monacolin statements and all “according to the FDA”/study percentage claims are unsupported because no red yeast rice labeling was provided; several Lipitor safety frequency framings are not supported by the provided Lipitor label excerpts.
Suggested Improvement
Limit claims to statements directly supported by the provided Lipitor label excerpts (e.g., MOA as HMG-CoA reductase inhibition; LDL-C reduction; adverse reactions explicitly listed with provided incidences). Remove or replace all red yeast rice/monacolin FDA-attribution and numerical incidence claims unless the specific red yeast rice regulatory/label text is supplied.